| Epidemiology of amyotrophic lateral sclerosis: an update of recent literature E Longinetti, F Fang Current opinion in neurology 32 (5), 771-776, 2019 | 481 | 2019 |
| The Swedish motor neuron disease quality registry E Longinetti, A Regodón Wallin, K Samuelsson, R Press, A Zachau, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19 (7-8), 528-537, 2018 | 82 | 2018 |
| Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis E Longinetti, D Mariosa, H Larsson, W Ye, C Ingre, C Almqvist, ... Neurology 89 (6), 578-585, 2017 | 47 | 2017 |
| Gender perspective of risk factors associated with disclosure of HIV status, a cross-sectional study in Soweto, South Africa E Longinetti, M Santacatterina, Z El-Khatib PloS one 9 (4), e95440, 2014 | 36 | 2014 |
| Physical and cognitive fitness in young adulthood and risk of amyotrophic lateral sclerosis at an early age E Longinetti, D Mariosa, H Larsson, C Almqvist, P Lichtenstein, W Ye, ... European Journal of Neurology 24 (1), 137-142, 2017 | 24 | 2017 |
| Correlates of mobile phone use in HIV care: Results from a cross-sectional study in South Africa N Madhvani, E Longinetti, M Santacatterina, BC Forsberg, Z El-Khatib Preventive medicine reports 2, 512-516, 2015 | 22 | 2015 |
| Sustained low relapse rate with highly variable B-cell repopulation dynamics with extended rituximab dosing intervals in multiple sclerosis C Starvaggi Cucuzza, E Longinetti, N Ruffin, B Evertsson, I Kockum, ... Neurology: Neuroimmunology & Neuroinflammation 10 (1), e200056, 2022 | 21 | 2022 |
| Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study C Cui, E Longinetti, H Larsson, J Andersson, Y Pawitan, F Piehl, F Fang Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22 (3-4), 211-219, 2021 | 19 | 2021 |
| Utilization of social media and web forums by HIV patients-A cross-sectional study on adherence and reported anxiety level E Longinetti, V Manoharan, H Ayoub, PJ Surkan, Z El-Khatib Preventive medicine reports 6, 137-143, 2017 | 17 | 2017 |
| COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls E Longinetti, H Bower, KA McKay, S Englund, J Burman, K Fink, ... Annals of Clinical and Translational Neurology 9 (9), 1449-1458, 2022 | 11 | 2022 |
| Risk of depression in multiple sclerosis across disease-modifying therapies E Longinetti, T Frisell, S Englund, J Reutfors, F Fang, F Piehl Multiple Sclerosis Journal 28 (4), 632-641, 2022 | 11 | 2022 |
| Heart rate, intelligence in adolescence, and Parkinson’s disease later in life E Longinetti, Y Zhan, M Sata, H Larsson, BM D′ Onofrio, H Iso, ... European Journal of Epidemiology, 1-10, 2021 | 9 | 2021 |
| History of violence/maltreatment and psychogenic non-epileptic seizures M Beghi, L Zhang, E Beghi, G Giussani, G Erba, E Longinetti, ... Seizure 81, 8-12, 2020 | 8 | 2020 |
| ALS patients with concurrent neuroinflammatory disorders; a nationwide clinical records study E Longinetti, O Sveinsson, R Press, W Ye, C Ingre, F Piehl, F Fang Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (3-4), 209-219, 2022 | 6 | 2022 |
| Geographical clusters of amyotrophic lateral sclerosis and the Bradford Hill criteria E Longinetti, E Pupillo, C Belometti, E Bianchi, M Poloni, F Fang, E Beghi Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (5-6), 329-343, 2022 | 4 | 2022 |
| Mortality among family members of patients with amyotrophic lateral sclerosis–a Swedish register-based study U Kläppe, E Longinetti, H Larsson, C Ingre, F Fang Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (3-4), 226-235, 2022 | 2 | 2022 |
| Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort S Englund, M Kierkegaard, J Burman, K Fink, A Fogdell-Hahn, ... Multiple Sclerosis and Related Disorders 70, 104481, 2023 | 1 | 2023 |
| Amyotrophic lateral sclerosis and multiple sclerosis associated neuroinflammation: nationwide epidemiological studies on etiology, comorbidities, and treatment E Longinetti PQDT-Global, 2019 | 1 | 2019 |
| Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy E Longinetti, S Englund, J Burman, K Fink, A Fogdell-Hahn, ... Journal of Neurology, Neurosurgery & Psychiatry 95 (2), 134-141, 2024 | | 2024 |
| Linking fatigue trajectories in relapsing-remitting multiple sclerosis to incidence of psychiatric comorbidities and productivity loss in the years following initiation of … S Englund, T Frisell, Y Qu, K Gandhi, A Hulten, F Piehl, E Longinetti MULTIPLE SCLEROSIS JOURNAL 29, 192-192, 2023 | | 2023 |
